Clinical evaluation of the safety and efficacy of a 1060 nm diode laser for non‐invasive fat reduction of the flanks

Background Laser hyperthermia‐induced lipolysis is a non‐invasive method of localized fat treatment. Non‐invasive approaches could be an option for a growing number of patients who are risk‐averse and are seeking out non‐invasive alternatives to surgical procedures such as liposuction. This study ev...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of cosmetic dermatology 2023-11, Vol.22 (11), p.3017-3025
Hauptverfasser: Kang, Alison, Kislevitz, Mikaela, Wamsley, Christine, Barillas, Jennifer, Hoopman, John, Kenkel, Jeffrey, Kilmer, Suzanne
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background Laser hyperthermia‐induced lipolysis is a non‐invasive method of localized fat treatment. Non‐invasive approaches could be an option for a growing number of patients who are risk‐averse and are seeking out non‐invasive alternatives to surgical procedures such as liposuction. This study evaluated the safety and efficacy of a 1060 nm diode laser for the non‐invasive fat reduction of the flanks. Methods A total of 30 subjects were enrolled in this prospective, single center study. Subjects received one 25‐min treatment with a 1060 nm diode laser to both flanks. Follow‐up visits were conducted at 6 and 12 weeks after the last treatment. Ultrasound adipose thickness, body weight, and circumference measurements were taken at baseline and at the 6‐ and 12‐week follow‐up visits. Subject satisfaction was assessed using a self‐assessment of fat reduction, pain, and tolerability scales, and a subject satisfaction questionnaire. Safety was assessed via the presence or absence of any adverse events. Results The average age of subjects was 47.3 years. A total of 27 subjects completed the treatment and returned for both follow‐up visits. An adipose reduction of 7.57 ± 1.15% at 6 weeks post‐treatment (p 
ISSN:1473-2130
1473-2165
DOI:10.1111/jocd.15954